COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 2895: Articles 28941-28950  | Next

SARS-CoV-2 Productively Infects Human Gut Enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., van Schayck, J. P., Mykytyn, A. Z., Duimel, H. Q., van Donselaar, E., Riesebosch, S., Kuijpers, H. J. H., Schipper, D., van de Wetering, W. J., de Graaf, M., Koopmans, M., Cuppen, E., Peters, P. J., Haagmans, B. L., Clevers, H.
10.1101/2020.04.25.060350 — Posted: 2020-04-25 Discussion: Offsite
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
Smithgall, M. C., Scherberkova, I., Whittier, S., Green, D.
10.1101/2020.04.22.055327 — Posted: 2020-04-25 Discussion: Onsite
Optimized qRT-PCR approach for the detection of intra- and extracellular SARS-CoV-2 RNAs
Toptan, T., Hoehl, S., Westhaus, S., Bojkova, D., Berger, A., Rotter, B., Hoffmeier, K., Ciesek, S., Widera, M.
10.1101/2020.04.20.052258 — Posted: 2020-04-25
Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands
Oude Munnink, B. B., Nieuwenhuijse, D. F., Stein, M., O'Toole, A., Haverkarte, M., Mollers, M., Kamga, S. K., Schapendonk, C., Lexmond, P., Pronk, M., van der Linden, A., Bestebroer, T., Chestakova, I., Overmars, R. J., van Nieuwkoop, S., Molenkamp, R., van der Eijck, A., GeurtsvanKessel, C., Vennema, H., Meijer, A., Rambaut, A., van Dissel, J., Sikkema, R., Timen, A., Koopmans, M.
10.1101/2020.04.21.050633 — Posted: 2020-04-25
MINERVA: A facile strategy for SARS-CoV-2 whole genome deep sequencing of clinical samples
Chen, C., Li, J., Di, L., Jing, Q., Du, P., Song, C., Li, J., Li, Q., Cao, Y., Xie, S., Wu, A. R., Zeng, H., Huang, Y., Wang, J.
10.1101/2020.04.25.060947 — Posted: 2020-04-25 Discussion: Offsite
CoV2ID: Detection and Therapeutics Oligo Database for SARS-CoV-2
Carneiro, J., Pereira, F.
10.1101/2020.04.19.048991 — Posted: 2020-04-25 Discussion: Offsite
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
McKay, P. F., Hu, K., Blakney, A. K., Samnuan, K., Bouton, C. R., Rogers, P., Polra, K., Lin, P. J. C., Barbosa, C., Tam, Y., Shattock, R. J.
10.1101/2020.04.22.055608 — Posted: 2020-04-25 Discussion: Offsite
The coronavirus proofreading exoribonuclease mediates extensive viral recombination
Gribble, J., Pruijssers, A. J., Agostini, M. L., Anderson-Daniels, J., Chappell, J. D., Lu, X., Stevens, L. J., Routh, A. L., Denison, M. R.
10.1101/2020.04.23.057786 — Posted: 2020-04-25 Discussion: Onsite
eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19
Mahari, S., Roberts, A., Shahdeo, D., Gandhi, S.
10.1101/2020.04.24.059204 — Posted: 2020-04-25
Expression of ACE2 and TMPRSS2, the SARS2-CoV-2 receptor and co-receptor, in prostate epithelial cells
Song, H., Seddighzadeh, B., Cooperberg, M. R., Huang, F. W.
10.1101/2020.04.24.056259 — Posted: 2020-04-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).